← Back to Search

Cannabinoid

Cannabidiol (CBD) for Breast Cancer

Q: Is there previous research on Cannabidiol (CBD) and its effects?

<p>There are 83 ongoing studies related to Cannabidiol (<a href="https://www.withpower.com/clinical-trials/cbd">CBD</a>), 18 of which are in Phase 3. While a few of the trials for CBD are taking place Ribeirao Preto, Sao Paulo, there are 311 research sites running these clinical trials.</p>

Phase 2

Waitlist Available

Led By Norah L Henry, MD, PhD

Research Sponsored by University of Michigan Rogel Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 15

Awards & highlights

Study Summary

This trial is testing the safety and effectiveness of a 15-week course of Cannabidol (CBD) in postmenopausal women with joint pain caused by Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS).

Eligible Conditions

Breast Cancer
Joint Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 15

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 15

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 15 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Absolute change in Brief Pain Inventory (BPI) worst pain from baseline to week 15

Secondary outcome measures

Change in symptoms from baseline, as measured by the PROMIS-29+2 Profile v2.1

Number of participants with undetectable levels of estradiol

Number of patients with at least a 2-point reduction in BPI average pain from baseline to week 15

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Cannabidiol (CBD)Experimental Treatment1 Intervention

Oral solution given 2x daily.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cannabidiol

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor

293 Previous Clinical Trials

24,057 Total Patients Enrolled

32 Trials studying Breast Cancer

3,948 Patients Enrolled for Breast Cancer

American Society of Clinical OncologyOTHER

33 Previous Clinical Trials

147,513 Total Patients Enrolled

7 Trials studying Breast Cancer

930 Patients Enrolled for Breast Cancer

Norah L Henry, MD, PhDPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

10 Previous Clinical Trials

529 Total Patients Enrolled

8 Trials studying Breast Cancer

427 Patients Enrolled for Breast Cancer

Media Library

Cannabidiol (CBD) (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT04754399 — Phase 2

Breast Cancer Research Study Groups: Cannabidiol (CBD)

Breast Cancer Clinical Trial 2023: Cannabidiol (CBD) Highlights & Side Effects. Trial Name: NCT04754399 — Phase 2

Cannabidiol (CBD) (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04754399 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the contraindications of CBD?

"CBD oil has received a score of 2 in terms of safety. This is due to the fact that, while there have been Phase 2 trials conducted which support its safety, there is no data currently available regarding efficacy."

Answered by AI

Are people still being sought out for this experiment?

"Yes, this study is still looking for patients to enroll. The listing on clinicaltrials.gov shows that the trial was originally posted on April 16th 2021 and updated September 21st, 2022."

Answered by AI

Is there previous research on Cannabidiol (CBD) and its effects?

"There are 83 ongoing studies related to Cannabidiol (CBD), 18 of which are in Phase 3. While a few of the trials for CBD are taking place Ribeirao Preto, Sao Paulo, there are 311 research sites running these clinical trials."

Answered by AI

How many individuals are part of this research?

"The clinicaltrials.gov website affirms that this research is, currently, looking for 44 individuals to take part in the study at a single site. The trial was originally advertised on April 16th 2021 and was last updated September 21st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

2021. "Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04754399.